"The Tulane Transplant Institute is located at Tulane Medical Center in Downtown New Orleans and provides liver, kidney and pancreas transplants from living donors and deceased donors."

During the past decade, Tulane Center for Abdominal Transplant conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tulane Center for Abdominal Transplant" are "Renal Transplantation" (2 trials), "Chronic Renal Failure" (1 trials), "Hyperplasia" (1 trials), "Immunosuppression in Solid Organ Transplant" (1 trials) and "Viruria" (1 trials). Many other conditions were trialed in "Tulane Center for Abdominal Transplant" in a lesser frequency.

Most popular intervention types in "Tulane Center for Abdominal Transplant" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Basiliximab" (1 trials), "Belatacept" (1 trials), "Belatacept Less Intensive (LI)" (1 trials), "Belatacept Less Intensive Regimen (LI)" (1 trials) and "Belatacept More Intensive (MI)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tulane Center for Abdominal Transplant" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Tulane Center for Abdominal Transplant". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tulane Center for Abdominal Transplant, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tulane Center for Abdominal Transplant, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".